These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 19926478

  • 1. CD4 mimics targeting the mechanism of HIV entry.
    Yamada Y, Ochiai C, Yoshimura K, Tanaka T, Ohashi N, Narumi T, Nomura W, Harada S, Matsushita S, Tamamura H.
    Bioorg Med Chem Lett; 2010 Jan 01; 20(1):354-8. PubMed ID: 19926478
    [Abstract] [Full Text] [Related]

  • 2. CD4 mimics targeting the HIV entry mechanism and their hybrid molecules with a CXCR4 antagonist.
    Narumi T, Ochiai C, Yoshimura K, Harada S, Tanaka T, Nomura W, Arai H, Ozaki T, Ohashi N, Matsushita S, Tamamura H.
    Bioorg Med Chem Lett; 2010 Oct 01; 20(19):5853-8. PubMed ID: 20728351
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis and evaluation of potential inhibitors of HIV gp120-CD4 interactions.
    Boussard C, Klimkait T, Mahmood N, Pritchard M, Gilbert IH.
    Bioorg Med Chem Lett; 2004 May 17; 14(10):2673-6. PubMed ID: 15109676
    [Abstract] [Full Text] [Related]

  • 4. Small molecular CD4 mimics as HIV entry inhibitors.
    Narumi T, Arai H, Yoshimura K, Harada S, Nomura W, Matsushita S, Tamamura H.
    Bioorg Med Chem; 2011 Nov 15; 19(22):6735-42. PubMed ID: 22014753
    [Abstract] [Full Text] [Related]

  • 5. A dynamic target-based pharmacophoric model mapping the CD4 binding site on HIV-1 gp120 to identify new inhibitors of gp120-CD4 protein-protein interactions.
    Caporuscio F, Tafi A, González E, Manetti F, Esté JA, Botta M.
    Bioorg Med Chem Lett; 2009 Nov 01; 19(21):6087-91. PubMed ID: 19783140
    [Abstract] [Full Text] [Related]

  • 6. Progress in targeting HIV-1 entry.
    Ryser HJ, Flückiger R.
    Drug Discov Today; 2005 Aug 15; 10(16):1085-94. PubMed ID: 16182193
    [Abstract] [Full Text] [Related]

  • 7. Inhibitors of HIV-1 attachment. Part 3: A preliminary survey of the effect of structural variation of the benzamide moiety on antiviral activity.
    Meanwell NA, Wallace OB, Wang H, Deshpande M, Pearce BC, Trehan A, Yeung KS, Qiu Z, Wright JJ, Robinson BA, Gong YF, Wang HG, Spicer TP, Blair WS, Shi PY, Lin PF.
    Bioorg Med Chem Lett; 2009 Sep 01; 19(17):5136-9. PubMed ID: 19632112
    [Abstract] [Full Text] [Related]

  • 8. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
    Zhao Q, Ma L, Jiang S, Lu H, Liu S, He Y, Strick N, Neamati N, Debnath AK.
    Virology; 2005 Sep 01; 339(2):213-25. PubMed ID: 15996703
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120.
    Neffe AT, Meyer B.
    Angew Chem Int Ed Engl; 2004 May 24; 43(22):2937-40. PubMed ID: 15170309
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CD4 mimics as HIV entry inhibitors: lead optimization studies of the aromatic substituents.
    Narumi T, Arai H, Yoshimura K, Harada S, Hirota Y, Ohashi N, Hashimoto C, Nomura W, Matsushita S, Tamamura H.
    Bioorg Med Chem; 2013 May 01; 21(9):2518-26. PubMed ID: 23535561
    [Abstract] [Full Text] [Related]

  • 17. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
    Zhang W, Canziani G, Plugariu C, Wyatt R, Sodroski J, Sweet R, Kwong P, Hendrickson W, Chaiken I.
    Biochemistry; 1999 Jul 20; 38(29):9405-16. PubMed ID: 10413516
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Binding of soluble recombinant HIV envelope glycoprotein, rgp120, induces conformational changes in the cellular membrane-anchored CD4 molecule.
    Yachou A, Sékaly RP.
    Biochem Biophys Res Commun; 1999 Nov 19; 265(2):428-33. PubMed ID: 10558884
    [Abstract] [Full Text] [Related]

  • 20. Design and optimisation of potent gp120-CD4 inhibitors.
    Tran TD, Adam FM, Calo F, Fenwick DR, Fok-Seang J, Gardner I, Hay DA, Perros M, Rawal J, Middleton DS, Parkinson T, Pickford C, Platts M, Randall A, Stephenson PT, Vuong H, Williams DH.
    Bioorg Med Chem Lett; 2009 Sep 01; 19(17):5250-5. PubMed ID: 19632839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.